Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Cardiology

What Causes Aortic Valve Stenosis and Faster Progression?

At a Glance

Aortic valve stenosis usually results from calcium buildup over time. Bicuspid valves, rheumatic fever, and prior chest radiation are other causes. Age, high blood pressure, cholesterol, diabetes, smoking, and kidney disease may increase risk, but no lifestyle change reopens a narrowed valve.

Aortic valve stenosis occurs when the leaflets (flaps) of your heart’s aortic valve become stiff, thick, and restricted, making it harder for the heart to pump blood out to your body. For most adults, this happens because of a gradual buildup of calcium on a normally formed valve over many years [1]. In other cases, the valve may narrow due to being born with an abnormal valve shape, delayed immune complications from childhood rheumatic fever, or undergoing prior radiation therapy to the chest [2][1]. While conditions like high blood pressure, high cholesterol, diabetes, and smoking are associated with the development or progression of this disease [3][4], managing these risk factors will not reopen a valve that is already narrowed [3][5].

An echocardiogram (an ultrasound of the heart) is used to look at the valve’s shape and measure how severe the narrowing has become [6]. Early calcium buildup is sometimes called aortic sclerosis; this means calcium is present, but it does not always mean the valve is severely narrowed yet.

Important Safety Note

When to seek help: Aortic valve stenosis can cause symptoms like exertional shortness of breath, chest pain, fainting, or a noticeable drop in your ability to exercise. If you experience new or worsening symptoms, contact your doctor promptly. If you experience severe chest pain, fainting, or severe breathlessness, seek emergency medical care.

Primary Causes of Valve Narrowing

Understanding why your valve narrowed usually comes down to a few primary causes:

  • Calcific Trileaflet Disease: Most people are born with a trileaflet valve (a valve with three flaps). Over decades of pumping blood, the constant mechanical stress can cause wear and tear. This leads to microcalcification (tiny calcium deposits) and inflammation that stiffen the valve [7][8]. This is not the same as the calcium in your diet or supplements; it is a complex biological process where the valve tissue actually begins to remodel and harden [7].
  • Bicuspid Aortic Valve (BAV) and Congenital Abnormalities: Some people are born with a bicuspid valve, meaning the valve only has two flaps instead of three [1]. Because a two-flap valve does not open and close as smoothly, it experiences higher mechanical stress [9]. This abnormal blood flow causes bicuspid valves to calcify and narrow much earlier in life than normal valves [2][9]. Patients with BAV may also experience valve leakage or enlargement of the aorta, and their first-degree relatives are often offered screening [10].
  • Rheumatic Heart Disease: A childhood strep throat infection (group A streptococcus) can sometimes trigger a delayed immune complication called rheumatic fever. This immune reaction causes inflammation that scars the heart valves (often the mitral and aortic valves) [11][12]. As this scar tissue heals, it can fuse the valve edges together, leading to stenosis years later. This is a more common cause of stenosis in younger patients and in regions of the world where rheumatic fever remains prevalent [11].
  • Prior Chest Radiation: Patients who received radiation therapy to the chest—often for cancers like Hodgkin’s lymphoma or breast cancer—can experience tissue scarring and premature calcification of the heart valves years or decades after their treatment [2].
Cause Typical Onset of Stenosis Key Feature
Calcific Trileaflet Disease Older Adulthood Gradual wear-and-tear and calcification of a normal 3-flap valve.
Bicuspid Aortic Valve (BAV) Middle Adulthood Congenital 2-flap valve that calcifies prematurely due to mechanical stress.
Rheumatic Heart Disease Varies (often younger) Scarring from a delayed immune reaction to a past childhood strep infection.
Prior Chest Radiation Years after treatment Scarring and calcification resulting from previous radiation therapy to the chest.

Factors Associated with Development or Progression

While the initial cause of your stenosis might be related to anatomy, age, or past exposures, certain health conditions are associated with the development of the disease or its faster progression in some studies.

  • Age: Growing older is the most substantial and consistent risk factor for calcific aortic valve disease, simply due to the decades of mechanical wear on the valve [13][3].
  • High Blood Pressure (Hypertension): Elevated blood pressure puts extra strain and physical force on the aortic valve as the heart pumps against higher resistance, which may be associated with inflammation and calcification [3].
  • Lipoprotein(a) and High Cholesterol: Dyslipidemia (abnormal cholesterol levels) is linked to valve calcification [3][14]. In particular, elevated Lipoprotein(a) or Lp(a)—an inherited lipoprotein particle in the blood that carries cholesterol—has strong evidence associating it with the initiation and calcification of aortic valve disease [15][16]. This is distinct from the standard LDL cholesterol measured on a routine lipid panel.
  • Diabetes: High blood sugar levels and clinical diabetes are associated with a greater prevalence of aortic valve calcification and a higher risk of developing aortic stenosis [4].
  • Smoking: Cigarette smoking damages blood vessels and is associated with developing stenosis, with some observational studies suggesting it may be linked to faster progression [3][14].
  • Chronic Kidney Disease (CKD): Poor kidney function alters how the body processes minerals, which may contribute to calcium building up on the valve, though the specific evidence for this is still developing [17].

Can Lifestyle Changes Reopen the Valve?

Many patients ask if changing their diet, taking medications, or improving their fitness can reverse the stenosis. Aortic valve stenosis is a structural, mechanical problem. Managing your risk factors—like lowering blood pressure, quitting smoking, and controlling blood sugar—is incredibly important for your overall cardiovascular health and for protecting your arteries [3][5].

However, improving these health metrics does not dissolve the calcium or reopen an established, narrowed valve [5]. Clinical trials have shown that cholesterol-lowering medications like statins do not reverse or slow the structural progression of aortic valve calcification [18][19]. Currently, no medication has been proven to reverse the disease [20].

Important Medication Note: Even though statins do not slow valve narrowing, you should never stop taking a prescribed statin, blood pressure medication, or diabetes medication without consulting your doctor. These medications are vital for preventing heart attacks, strokes, and other cardiovascular complications.

Once the narrowing becomes severe and causes symptoms, the established treatment is valve replacement, which may be done through traditional open-heart surgery (SAVR) or a minimally invasive catheter procedure (TAVR/TAVI) [21][22]. A specialist heart team will determine the safest and most appropriate approach for you based on your anatomy, age, and overall health.

Common questions in this guide

What is the most common cause of aortic valve stenosis?
In adults, the most common cause is gradual calcium buildup and stiffening of a normally formed, three-leaflet aortic valve over many years. Older age is the strongest consistent risk factor for this calcific form of the disease.
Can a bicuspid aortic valve lead to aortic stenosis?
Yes. A bicuspid valve has two leaflets instead of three, so it can experience extra mechanical stress and calcify earlier in life. It can also be associated with aortic enlargement, and close relatives may be offered screening.
What health conditions can make aortic stenosis progress faster?
High blood pressure, abnormal cholesterol levels, elevated Lipoprotein(a), diabetes, smoking, and chronic kidney disease are associated with the development or progression of aortic stenosis. These factors do not affect every patient in the same way, so your clinician should assess your individual risk.
Can lifestyle changes or statins reopen a narrowed aortic valve?
No proven medication or lifestyle change can dissolve established calcium and reopen a narrowed aortic valve. Controlling blood pressure, blood sugar, cholesterol, and smoking remains important for overall heart and blood-vessel health, and prescribed medicines should not be stopped without medical advice.
Can rheumatic fever or chest radiation cause aortic valve stenosis?
Yes. Rheumatic fever after a childhood group A streptococcal infection can scar and fuse valve edges, while chest radiation can cause scarring and premature valve calcification years or decades later. These causes may be especially relevant when stenosis develops at a younger age or after cancer treatment.
How do doctors determine what is causing aortic stenosis and how severe it is?
An echocardiogram uses ultrasound to show the valve's shape and measure how much it has narrowed. It can help identify a bicuspid valve and assess measures such as valve area and pressure gradient, which your clinician uses to grade severity.
Which symptoms of aortic stenosis need urgent medical attention?
New or worsening shortness of breath with activity, chest pain, fainting, or a marked drop in exercise ability should be reported promptly. Severe chest pain, fainting, or severe breathlessness requires emergency medical care.

Get notified when new evidence is published on aortic valve stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (22)
  1. 1

    Genetic and Developmental Contributors to Aortic Stenosis.

    Dutta P, James JF, Kazik H, Lincoln J

    Circulation research 2021; (128(9)):1330-1343 doi:10.1161/CIRCRESAHA.120.317978.

    PMID: 33914609
  2. 2

    Etiology and distribution of isolated aortic stenosis in Indian patients - A study from a large tertiary care hospital in north India.

    Sahu AK, Sagar P, Khanna R, et al.

    Indian heart journal 2020; (72(4)):272-277 doi:10.1016/j.ihj.2020.06.013.

    PMID: 32861382
  3. 3

    Risk factors for valvular calcification.

    Chen HY, Engert JC, Thanassoulis G

    Current opinion in endocrinology, diabetes, and obesity 2019; (26(2)):96-102 doi:10.1097/MED.0000000000000471.

    PMID: 30694830
  4. 4

    Diabetes and elevated plasma glucose in heart valve calcification and disease: the Copenhagen General Population Study.

    Kaltoft M, Afzal S, Nordestgaard BG, et al.

    European journal of preventive cardiology 2025; (32(17)):1741-1750 doi:10.1093/eurjpc/zwaf106.

    PMID: 40036235
  5. 5

    Ten-year trajectory of Life's Essential 8 and aortic valve calcification.

    Wu Z, Gui M, Huang W, et al.

    American journal of preventive cardiology 2026; (27()):101542 doi:10.1016/j.ajpc.2026.101542.

    PMID: 42291075
  6. 6

    Intraoperative Diagnosis of Subaortic Stenosis in a Young Patient Scheduled for Elective Aortic Valve Replacement.

    Elgamal H, Borger M, Ender J, Meineri M

    A&A practice 2020; (14(10)):e01288 doi:10.1213/XAA.0000000000001288.

    PMID: 32845111
  7. 7

    The Role of Endoplasmic Reticulum Stress in Calcific Aortic Valve Disease.

    Liu X, Li T, Sun J, Wang Z

    The Canadian journal of cardiology 2023; (39(11)):1571-1580 doi:10.1016/j.cjca.2023.07.025.

    PMID: 37516250
  8. 8

    Calcific aortic valve disease: mechanisms, prevention and treatment.

    Moncla LM, Briend M, Bossé Y, Mathieu P

    Nature reviews. Cardiology 2023; (20(8)):546-559 doi:10.1038/s41569-023-00845-7.

    PMID: 36829083
  9. 9

    Molecular and Mechanical Mechanisms of Calcification Pathology Induced by Bicuspid Aortic Valve Abnormalities.

    Kazik HB, Kandail HS, LaDisa JF, Lincoln J

    Frontiers in cardiovascular medicine 2021; (8()):677977 doi:10.3389/fcvm.2021.677977.

    PMID: 34124206
  10. 10

    Aortic Stenosis Progression: Lessons From Multimodality Imaging.

    Jain R, Padang R, Postalian A, et al.

    Mayo Clinic proceedings 2026; doi:10.1016/j.mayocp.2026.06.008.

    PMID: 42285495
  11. 11

    Transcatheter Aortic Valve Implantation in Young Patients: Challenges and Perspectives-A Narrative Review.

    Moț IDD, Șerban AM, Achim A, et al.

    Journal of clinical medicine 2025; (14(19)) doi:10.3390/jcm14196847.

    PMID: 41095927
  12. 12

    Recent updates on asymptomatic and symptomatic aortic valve stenosis its diagnosis, pathogenesis, management and future perspectives.

    Sandeep B, Liu X, Wu Q, et al.

    Current problems in cardiology 2024; (49(7)):102631 doi:10.1016/j.cpcardiol.2024.102631.

    PMID: 38729278
  13. 13

    The global burden of calcified aortic valve stenosis: epidemiology, risk factors, disparities, and future perspectives - a narrative review.

    Hemelrijk KI, Delewi R, Mehran R, Boekholdt SM

    Atherosclerosis 2026; (417()):120731 doi:10.1016/j.atherosclerosis.2026.120731.

    PMID: 42177117
  14. 14

    Association Between Plasma Lipoprotein Levels and Aortic Valve Calcification Among Patients with Aortic Valve Replacement Surgery: A Retrospective Study.

    Tao T, Zheng J, Han Y, et al.

    International journal of general medicine 2022; (15()):4665-4673 doi:10.2147/IJGM.S363989.

    PMID: 35548590
  15. 15

    Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study.

    Kaltoft M, Sigvardsen PE, Afzal S, et al.

    Atherosclerosis 2022; (349()):166-174 doi:10.1016/j.atherosclerosis.2021.11.029.

    PMID: 34903381
  16. 16

    Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve Microcalcification.

    Perrot N, Thériault S, Dina C, et al.

    JAMA cardiology 2019; (4(7)):620-627 doi:10.1001/jamacardio.2019.1581.

    PMID: 31141105
  17. 17

    Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification.

    Ozkan U, Ozcelik F, Yildiz M, Budak M

    Journal of cardiovascular development and disease 2019; (6(3)) doi:10.3390/jcdd6030031.

    PMID: 31455005
  18. 18

    Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy.

    Kraler S, Blaser MC, Aikawa E, et al.

    European heart journal 2022; (43(7)):683-697 doi:10.1093/eurheartj/ehab757.

    PMID: 34849696
  19. 19

    Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in "Treating" Aortic Valve Calcification.

    Tsamoulis D, Siountri I, Rallidis LS

    Journal of cardiovascular development and disease 2023; (10(3)) doi:10.3390/jcdd10030096.

    PMID: 36975859
  20. 20

    Lipoprotein(a) and calcific aortic valve disease: current evidence and future directions.

    Lan NSR, Khan Z, Watts GF

    Current opinion in clinical nutrition and metabolic care 2024; (27(1)):77-86 doi:10.1097/MCO.0000000000000976.

    PMID: 37650693
  21. 21

    Lipoprotein(a) and calcific aortic stenosis: from inherited risk marker to therapeutic target.

    Epelde F

    Frontiers in medicine 2026; (13()):1908850 doi:10.3389/fmed.2026.1908850.

    PMID: 42620888
  22. 22

    Lipoprotein(a): Expanding our knowledge of aortic valve narrowing.

    Youssef A, Clark JR, Koschinsky ML, Boffa MB

    Trends in cardiovascular medicine 2021; (31(5)):305-311 doi:10.1016/j.tcm.2020.06.001.

    PMID: 32525013

This page explains causes and risk factors for aortic valve stenosis for informational purposes only and does not constitute medical advice. Your clinician should interpret your echocardiogram, symptoms, and personal risk.